Top 10 Players in the Vietnam Hydroxychloroquine Market | Insights 2026

Top 10 Players in the Vietnam Hydroxychloroquine Market

The Vietnam HydroxychloroquineMarket is characterized by a strong presence of domestic pharmaceutical manufacturers, and international distributors, that guarantees the consistent availability of disease-modifying anti-rheumatic drugs (DMARDs), and antimalarial therapeutics. Key players in the market are DHG Pharmaceutical Joint Stock Company (DHG Pharma), Traphaco Joint Stock Company, and other well-known healthcare companies engaged in the manufacture and distribution of essential autoimmune and chronic care therapies.

Vietnam Hydroxychloroquine Market Overview

According to 6Wresearch, the Vietnam Hydroxychloroquine market growth is driven by the rising incidence of autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), rheumatoid arthritis, and juvenile idiopathic arthritis. Hydroxychloroquine sulphate is a keystone of immunomodulatory therapy in these diseases, and critical for preventing long-term structural damage in patients.

Government initiatives to improve the national healthcare infrastructure, such as the increase in health insurance coverage, and the adoption of standardized clinical treatment protocols by the Ministry of Health, have stabilized the supply chain. These initiatives help to ensure that vital medicines are available for patients, to follow long term treatment plans in urban centres.

Competitive landscape

The competitive landscape of the Vietnam Hydroxychloroquine Industry is a combination of strong and modernized domestic manufacturing companies, along with well-established international pharmaceutical companies. Major companies sustain their market share through adherence to GMP standards, and the development of efficient distribution networks linking high-tech manufacturing facilities to regional hospital pharmacies.

List of leading players operating in the Vietnam Hydroxychloroquine Market:

1. DHG Pharmaceutical Joint Stock Company (DHG Pharma)

DHG Pharma is one of Vietnam’s leading pharmaceutical companies, with a vast distribution network that ensures the availability of essential medications.

2. Traphaco Joint Stock Company

Traphaco is a trusted name in the market, focused on delivering high-quality, reliable ethical medicines that cater to long-term health needs.

3. Pymepharco Joint Stock Company

Pymepharco specializes in high-standard pharmaceutical manufacturing, significantly contributing to the local availability of essential oral dosage forms.

4. Imexpharm Corporation

Imexpharm maintains a strong presence in the high-tech pharmaceutical sector, focusing on meeting international quality standards for medical use.

5. Domesco Medical Import-Export Joint Stock Corporation

Domesco is recognized for its commitment to pharmaceutical innovation, and its strategic role in supplying a wide range of specialty medicines.

6. Ha Tay Pharmaceutical Joint Stock Company (HATAPHAR)

HATAPHAR leverages decades of manufacturing experience to produce reliable pharmaceutical products.

7. OPC Pharmaceutical Joint Stock Company

OPC provides robust pharmaceutical manufacturing capabilities, ensuring the consistent quality and safety of essential formulations.

8. Cuu Long Pharmaceutical Joint Stock Corporation (PHARIMEXCO)

PHARIMEXCO is widely regarded for its extensive regional distribution reach, ensuring that essential health products remain accessible.

9. Sanofi Vietnam

Sanofi excels in the development and marketing of specialized treatments for chronic diseases, maintaining high global standards for therapeutic efficacy.

10. STADA Vietnam

STADA plays a vital role in the Vietnamese healthcare supply chain by integrating international expertise to support the needs of the local clinical community.

Top 10 Players in the Vietnam Hydroxychloroquine Market: FAQs